Skip to Content

Fel-O-Vax IV + CaliciVax

This page contains information on Fel-O-Vax IV + CaliciVax for veterinary use.
The information provided typically includes the following:
  • Fel-O-Vax IV + CaliciVax Indications
  • Warnings and cautions for Fel-O-Vax IV + CaliciVax
  • Direction and dosage information for Fel-O-Vax IV + CaliciVax

Fel-O-Vax IV + CaliciVax

This treatment applies to the following species:
Company: Elanco US

Feline Rhinotracheitis-Calici-Panleukopenia-Chlamydia Psittaci Vaccine

Killed Virus, Killed Chlamydia

For use in animals only

This product has been shown to be effective for the vaccination of of healthy cats 8 weeks of age or older against feline rhinotracheitis, calici, panleukopenia viruses and feline chlamydia psittaci. The duration of immunity for this product has not been established. For more information regarding efficacy and safety data, go to productdata.aphis.usda.gov. The vaccine contains one additional feline calicivirus strain isolated from one hemorrhagic calicivirus outbreak that occurred in 1998 and was shown to be effective against calicivirus induced hemorrhagic disease in controlled vaccination challenge experiments.

For more information regarding efficacy and safety data, go to productdata.aphis.usda.gov.

Dose: Inject one 1 mL dose subcutaneously using aseptic technique. Healthy cats should receive two doses, 3 to 4 weeks apart, except that if the animal is less than 16 weeks of age, then the final dose should be given no earlier than 16 weeks of age. The presence of maternal antibody is known to interfere with the development of active immunity in cats and additional boosters will be required in most young animals. The need for annual booster revaccinations has not been established for this product. For advice on revaccination frequency and annual booster vaccinations, consultation with a veterinarian is recommended.

Fel-O-Vax IV + CaliciVax Caution

Store in the dark at 2° to 8°C (35° to 46°F). Avoid freezing. Shake well. Do not mix with other products, except as specified on the label. This product has not been tested in pregnant animals. In case of anaphylactoid reaction, administer epinephrine. In case of human exposure, contact a physician.

Thimerosal, neomycin, polymyxin B and amphotericin B added as preservatives.

Fel-O-Vax IV + CaliciVax Caution

In the absence of a veterinarian-client-patient relationship, Federal law prohibits the relabeling, repackaging, resale, or redistribution of the individual contents of this package.

© 2017 Elanco US Inc. all rights reserved.

Elanco US Inc., Fort Dodge, Iowa 50501

phone: 888-545-5973

VLN/PCN 196/16E5.23

Fel-O-Vax, CaliciVax, Elanco and the diagonal bar logo are trademarks of Elanco or its affiliates.

25 Doses

25-1 mL Vials of Vaccine

YL102111X

CPN: 1943004.1

ELANCO US INC.
FORT DODGE, IA, 50501
Customer Service:   317-276-1262
Technical Service:   800-428-4441
Website:   www.elanco.us
Email:   elanco@elanco.com
Every effort has been made to ensure the accuracy of the Fel-O-Vax IV + CaliciVax information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.

Copyright © 2019 Animalytix LLC. Updated: 2019-09-30

Hide